{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:50:23Z","timestamp":1768967423067,"version":"3.49.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To describe ambulatory care pharmacists\u2019 beliefs and confidence in managing diabetes in perinatal women through guided interviews based on the Theory of Planned Behavior (TPB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative study consisted of a web-based presurvey and semistructured virtual interviews with ambulatory care pharmacists practicing at a federally qualified health center (FQHC) system to elicit salient beliefs about managing diabetes in perinatal women using the following TPB constructs: behavioral beliefs (BB), normative beliefs (NB), and control beliefs (CB). Descriptive statistics were conducted for quantitative data. Interviews were transcribed and analyzed by 2 independent researchers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The pharmacist participants (N = 8) were all female and predominantly white (62.5%) and 35 to 44 years of age (87.5%). The majority (87.5%) were board certified in ambulatory care pharmacy, with 6 or more years of experience (75%). When the pharmacists were asked to rate the frequency of their involvement in managing diabetes in perinatal women in current or previous practice settings on a 5-point Likert scale (1 = never, 2 = rarely, 3 = sometimes, 4 = often, 5 = always), the mean (SD) score was 2.9 (1.1). When the pharmacists were asked to rate their confidence in their ability to manage diabetes in perinatal populations on a different Likert scale, the mean (SD) score of 3.8 (1.0) indicated a moderate level of confidence. Thirteen salient beliefs emerged (BB, n = 5; NB, n = 4; CB, n = 4), and pharmacists had positive BB, positive NB, and negative CB toward managing diabetes in perinatal women. \u201cImproved patient outcomes\u201d was the most prevalent BB. For NB, all participants expressed that patients would be in support of pharmacists managing their diabetes in pregnancy. For CB, restrictive collaborative practice agreements emerged as the most salient barrier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pharmacists who participated in this study were not routinely involved in perinatal diabetes management despite being moderately confident in their ability to provide such services, having positive BB, and believing their patients would be supportive. Pharmacists had negative CB, and future interventions can focus on addressing these barriers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxag003","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:46:22Z","timestamp":1767789982000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploring ambulatory care pharmacists\u2019 beliefs and confidence in managing diabetes in perinatal women: A qualitative study guided by the Theory of Planned Behavior"],"prefix":"10.1093","author":[{"given":"Heeseung J","family":"Mueller","sequence":"first","affiliation":[{"name":"Health Outcomes Division, College of Pharmacy, The University of Texas at Austin , Austin, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie C","family":"Barner","sequence":"additional","affiliation":[{"name":"Health Outcomes Division, College of Pharmacy, The University of Texas at Austin , Austin, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria N","family":"Odonkor","sequence":"additional","affiliation":[{"name":"Health Outcomes Division, College of Pharmacy, The University of Texas at Austin , Austin, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn M","family":"Brown","sequence":"additional","affiliation":[{"name":"Health Outcomes Division, College of Pharmacy, The University of Texas at Austin , Austin, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan P","family":"Stewart","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Division, College of Pharmacy, The University of Texas at Austin , Austin, TX, and CommUnityCare Health Centers, Austin, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2026012010413413100_zxag003-B1"},{"key":"2026012010413413100_zxag003-B2","author":"Hoyert"},{"key":"2026012010413413100_zxag003-B3","author":"Healthy People","year":"2030"},{"key":"2026012010413413100_zxag003-B4","article-title":"Pregnancy-Related Deaths: Data from Maternal Mortality Review Committees in 36 US States, 2017-2019. Centers for Disease Control and Prevention","author":"Trost","year":"2022"},{"key":"2026012010413413100_zxag003-B5","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:113967","volume-title":"Maternal Mortality Rates in the United States, 2020","author":"Hoyert","year":"2022"},{"key":"2026012010413413100_zxag003-B6","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:103855","volume-title":"Maternal Mortality Rates in the United States, 2019","author":"Hoyert","year":"2021"},{"key":"2026012010413413100_zxag003-B7","author":"Centers for Disease Control and Prevention. Gestational diabetes"},{"issue":"5","key":"2026012010413413100_zxag003-B8","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.ajog.2004.03.074","article-title":"The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control","volume":"191","author":"Yogev","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2026012010413413100_zxag003-B9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","article-title":"Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis","volume":"62","author":"Kramer","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"2026012010413413100_zxag003-B10","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1542\/neo.18-1-e33","article-title":"Diabetes mellitus in pregnancy","volume":"18","author":"Sutton","year":"2017","journal-title":"Neoreviews"},{"issue":"1","key":"2026012010413413100_zxag003-B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15620\/cdc:122047","article-title":"Births: final data for 2021","volume":"72","author":"Osterman","year":"2023","journal-title":"Natl Vital Stat Rep"},{"issue":"3","key":"2026012010413413100_zxag003-B12","first-page":"1","article-title":"Trends and characteristics in gestational diabetes: United States, 2016-2020","volume":"71","author":"Gregory","year":"2022","journal-title":"Natl Vital Stat Rep"},{"key":"2026012010413413100_zxag003-B13","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:127679","volume-title":"Trends and Characteristics in Prepregnancy Diabetes: United States, 2016\u20132021","author":"Gregory","year":"2023"},{"key":"2026012010413413100_zxag003-B14"},{"issue":"1","key":"2026012010413413100_zxag003-B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1331\/JAPhA.2008.07140","article-title":"The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia","volume":"48","author":"Bunting","year":"2008","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"11","key":"2026012010413413100_zxag003-B16","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1002\/phar.1650","article-title":"Implementation and clinical outcomes of an employer-sponsored, pharmacist-provided medication therapy management program","volume":"35","author":"Theising","year":"2015","journal-title":"Pharmacotherapy"},{"key":"2026012010413413100_zxag003-B17","doi-asserted-by":"publisher","first-page":"E108","DOI":"10.5888\/pcd17.200063","article-title":"The Mississippi Delta Health Collaborative medication therapy management model: public health and pharmacy working together to improve population health in the Mississippi Delta","volume":"17","author":"Ross","year":"2020","journal-title":"Prev Chronic Dis"},{"issue":"9","key":"2026012010413413100_zxag003-B18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.clinthera.2014.06.030","article-title":"Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial","volume":"36","author":"Hirsch","year":"2014","journal-title":"Clin Ther"},{"issue":"1","key":"2026012010413413100_zxag003-B19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/jama.2013.6549","article-title":"Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial","volume":"310","author":"Margolis","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"2026012010413413100_zxag003-B20","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1331\/JAPhA.2009.08181","article-title":"Translating clinical guidelines into clinical practice: role of the pharmacist in type 2 diabetes management","volume":"49","author":"Drab","year":"2009","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2026012010413413100_zxag003-B21","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.5888\/pcd17.190377","article-title":"Using an advanced practice pharmacist in a team-based care model to decrease time to hemoglobin A1c goal among patients with type 2 diabetes, Florida, 2017-2019","volume":"17","author":"Cowart","year":"2020","journal-title":"Prev Chronic Dis."},{"issue":"1","key":"2026012010413413100_zxag003-B22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/13561820.2019.1633289","article-title":"The impact of a pharmacist-driven, collaborative practice on diabetes management in an urban underserved population: a mixed method assessment","volume":"34","author":"Ray","year":"2020","journal-title":"J Interprof Care"},{"issue":"6","key":"2026012010413413100_zxag003-B23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1345\/aph.1S079","article-title":"Pharmacist-physician collaboration for diabetes care: the diabetes initiative program","volume":"47","author":"Farland","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"2","key":"2026012010413413100_zxag003-B24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.18553\/jmcp.2018.24.2.114","article-title":"Evaluation of a pharmacist-managed diabetes program in a primary care setting within an integrated health care system","volume":"24","author":"Benedict","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"10","key":"2026012010413413100_zxag003-B25","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1177\/1060028017711454","article-title":"Impact of diabetes care by pharmacists as part of health care team in ambulatory settings: a systematic review and meta-analysis","volume":"51","author":"Fazel","year":"2017","journal-title":"Ann Pharmacother"},{"key":"2026012010413413100_zxag003-B26","author":"Smith"},{"key":"2026012010413413100_zxag003-B27","author":"Srinivasa"},{"issue":"10","key":"2026012010413413100_zxag003-B28","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.26.10.1301","article-title":"Perceptions of the value of clinical pharmacy medication review for women during early pregnancy","volume":"26","author":"Lee","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"2026012010413413100_zxag003-B29","author":"Sallam"},{"issue":"15","key":"2026012010413413100_zxag003-B30","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/ajhp\/zxad092","article-title":"Obstetric clinical pharmacy: a necessary birth of a new specialty","volume":"80","author":"Small","year":"2023","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"2026012010413413100_zxag003-B31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0749-5978(91)90020-T","article-title":"The theory of planned behavior","volume":"50","author":"Ajzen","year":"1991","journal-title":"Organ Behav Hum Decis Process"},{"key":"2026012010413413100_zxag003-B32"},{"key":"2026012010413413100_zxag003-B33"},{"key":"2026012010413413100_zxag003-B34","doi-asserted-by":"publisher","DOI":"10.4324\/9780203793206","volume-title":"Discovery of Grounded Theory: Strategies for Qualitative Research","author":"Glaser","year":"2017"},{"key":"2026012010413413100_zxag003-B35","doi-asserted-by":"publisher","first-page":"100174","DOI":"10.1016\/j.ijnsa.2024.100174","article-title":"Saturation in qualitative research: An evolutionary concept analysis","volume":"6","author":"Rahimi","year":"2024","journal-title":"Int J Nurs Stud Adv"},{"key":"2026012010413413100_zxag003-B36","article-title":"Constructing a Theory of Planned Behavior questionnaire","author":"Ajzen"},{"issue":"3","key":"2026012010413413100_zxag003-B37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12144-003-1019-1","article-title":"Eliciting salient beliefs in research on the theory of planned behaviour: the effect of question wording","volume":"22","author":"Sutton","year":"2003","journal-title":"Curr Psychol"},{"key":"2026012010413413100_zxag003-B38","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1186\/s12913-022-08788-4","article-title":"Applying the Theory of Planned Behavior to predict community pharmacists\u2019 intention to provide diabetes care","volume":"22","author":"EL-Kaffash","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"2026012010413413100_zxag003-B39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pcd.2022.02.003","article-title":"Effectiveness of clinical pharmacist-led smartphone application on medication adherence, insulin injection technique and glycemic control for women with gestational diabetes receiving multiple daily insulin injection: a randomized clinical trial","volume":"16","author":"Zhuo","year":"2022","journal-title":"Prim Care Diabetes"},{"issue":"5","key":"2026012010413413100_zxag003-B40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.31083\/j.ceog.2020.05.2212","article-title":"Impact of clinical pharmacist intervention on blood glucose control and perinatal outcomes in gestational diabetes mellitus through a diabetes management system","volume":"47","author":"Ji","year":"2020","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"1","key":"2026012010413413100_zxag003-B41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11096-017-0550-3","article-title":"Impact of clinical pharmacists intervention on management of hyperglycemia in pregnancy in Jordan","volume":"40","author":"Batta","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"2026012010413413100_zxag003-B42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/fampra\/cmh503","article-title":". Providing health care to low-income women: a matter of trust","volume":"21","author":"Sheppard","year":"2004","journal-title":"Fam Pract"},{"key":"2026012010413413100_zxag003-B43","doi-asserted-by":"publisher","first-page":"100267","DOI":"10.1016\/j.rcsop.2023.100267","article-title":"A descriptive analysis of primary care providers\u2019 interest in clinical pharmacy services","volume":"10","author":"Gutierrez Euceda","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2026012010413413100_zxag003-B44","volume-title":"ACCP Ambulatory Care Pharmacist\u2019s Survival Guide","author":"Evoy","year":"2024","edition":"Fifth Edition"},{"issue":"2","key":"2026012010413413100_zxag003-B45","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.18549\/PharmPract.2021.2.2359","article-title":"Bridging health disparities: a national survey of ambulatory care pharmacists in underserved areas","volume":"19","author":"Stewart","year":"2021","journal-title":"Pharm Pract (Granada)"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag003\/66312817\/zxag003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag003\/66312817\/zxag003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:41:40Z","timestamp":1768923700000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article\/doi\/10.1093\/ajhp\/zxag003\/8417539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag003","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"article-number":"zxag003"}}